To help strengthen the translation of fundamental research towards patient benefit. It supports:
1. Research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant.
2. Studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.